Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Berinert	0	18
Total, all-cause mortality	CSL830 (Low Dose)	0	12
Total, all-cause mortality	CSL830 (Medium Dose)	0	12
Total, all-cause mortality	CSL830 (High Dose)	0	12
Total, other adverse events	Berinert	4	18
Total, other adverse events	CSL830 (Low Dose)	10	12
Total, other adverse events	CSL830 (Medium Dose)	8	12
Total, other adverse events	CSL830 (High Dose)	9	12
Total, serious adverse events	Berinert	1	18
Total, serious adverse events	CSL830 (Low Dose)	0	12
Total, serious adverse events	CSL830 (Medium Dose)	0	12
Total, serious adverse events	CSL830 (High Dose)	1	12

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01576523/event-totals